Company Guangzhou Wondfo Biotech Co.,Ltd

Equities

300482

CNE100002102

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Ratings for Guangzhou Wondfo Biotech Co.,Ltd

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Diagnostic & Testing Substances

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
27.67 ^CNY	+3.79%		+8.55%	-8.29%

Apr. 21	Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

GUANGZHOU WONDFO BIOTECH CO., LTD. is a China-based company principally engaged in research, manufacture and sales of point-of-care testing (POCT) reagents, POCT instrument and related products. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The Company's products are used in POCT, clinical test, field test and personal health management, among others.

Number of employees: 3,404

CNY in Million	2022	Weight	2023	Weight	Delta
Chronic Disease Detection 40.5 %	939	16.5 %	1,119	40.5 %	+19.11%
Infectious Disease Detection 34.4 %	3,936	69.3 %	952	34.4 %	-75.82%
Drug (Substance Abuse) Testing 12.0 %	294	5.2 %	331	12.0 %	+12.68%
Pregnancy and Eugenics Testing 9.7 %	242	4.3 %	267	9.7 %	+10.08%
Other 3.5 %	269	4.7 %	97	3.5 %	-63.91%

CNY in Million	2022	Weight	2023	Weight	Delta
China 72.2 %	2,873	50.6 %	1,995	72.2 %	-30.56%
Overseas 27.8 %	-	-	770	27.8 %	-

Managers	Title	Age	Since
Zhong Xiong Peng CEO	Chief Executive Officer	50	09-12-31
Ji Hua Wang FOU	Founder	61	91-12-31
Wen Mei Li FOU	Founder	61	91-12-31
Fang Xia Yu DFI	Director of Finance/CFO	47	04-12-31
Qing Mei Song BRD	Director/Board Member	46	97-12-31
Xiao Wei He BRD	Director/Board Member	65	99-12-31
Jun Hua IRC	Investor Relations Contact	-	-
Hong Hu SEC	Corporate Secretary	41	18-05-31
Ke Ren Kang PRN	Corporate Officer/Principal	47	12-03-31
Ya Ping Zhao SAM	Sales & Marketing	47	09-12-31

Members of the board	Title	Age	Since
Wen Mei Li FOU	Founder	61	91-12-31
Cui Ling Wu CHM	Chairman	62	12-04-10
Ji Hua Wang FOU	Founder	61	91-12-31
Xiao Wei He BRD	Director/Board Member	65	99-12-31
Ke Ren Kang PRN	Corporate Officer/Principal	47	12-03-31
Jin Qi Chen BRD	Director/Board Member	64	18-06-11
Zhong Xiong Peng CEO	Chief Executive Officer	50	09-12-31
Qing Mei Song BRD	Director/Board Member	46	97-12-31
Xin Hua Ge BRD	Director/Board Member	57	23-04-20
Zhao Hui Duan BRD	Director/Board Member	55	21-08-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	474,124,211	267,103,536 ( 56.34 %)	2,157,633 ( 0.4551 %)	56.34 %

Name	Equities	%	Valuation
Canton Venture Capital Co. Ltd. 14.96 %	49,195,579	14.96 %	167 M ¥
Wen Mei Li 7.438 %	24,460,992	7.438 %	83 M ¥
Ji Hua Wang 3.770 %	12,398,685	3.770 %	42 M ¥
Hwabao WP Fund Management Co., Ltd. 2.525 %	8,303,738	2.525 %	28 M ¥
Guangzhou State-Owned Assets Supervision & Admin. Commission 1.571 %	5,168,088	1.571 %	18 M ¥
GUANGZHOU WONDFO BIOTECH CO.,LTD 1.104 %	3,632,210	1.104 %	12 M ¥
China Southern Asset Management Co., Ltd. 0.6421 %	2,111,887	0.6421 %	7 M ¥
Li Zhong Dai 0.5131 %	1,687,539	0.5131 %	6 M ¥
GF Fund Management Co., Ltd. 0.4370 %	1,437,165	0.4370 %	5 M ¥
Maxwealth Fund Management Co., Ltd. 0.3149 %	1,035,670	0.3149 %	4 M ¥

Name	Equities	%	Valuation
Wen Mei Li 65.48 %	73,382,976	65.48 %	250 M ¥
Ji Hua Wang 33.19 %	37,196,055	33.19 %	127 M ¥
Xiao Wei He 0.4142 %	464,242	0.4142 %	2 M ¥
Ya Ping Zhao 0.0650 %	72,800	0.0650 %	247 789 ¥
Zhong Xiong Peng 0.0650 %	72,800	0.0650 %	247 789 ¥
Fang Xia Yu 0.0487 %	54,600	0.0487 %	185 841 ¥

Name	Equities	%	Valuation
GUANGZHOU WONDFO BIOTECH CO.,LTD 1.10%	3,632,210	1.10%	12,362,917 $

Guangzhou Wondfo Biotech Co., Ltd.

8 Lizhishan Road Science City

510641, Guangzhou

+86 40 0830 8768

http://www.wondfo.com.cn

address Guangzhou Wondfo Biotech Co.,Ltd(300482)

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.67 CNY

Average target price

31.73 CNY

Spread / Average Target

+14.66%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.29%	1.79B
BIOMÉRIEUX	-0.60%	12.63B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9.59%	7.67B
DIASORIN S.P.A.	+1.82%	5.42B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.02%	4.57B
10X GENOMICS, INC.	-47.68%	3.51B
ANDON HEALTH CO., LTD.	+6.42%	2.59B
VITROLIFE AB	-14.59%	2.05B
MYRIAD GENETICS, INC.	+2.25%	1.77B
SANSURE BIOTECH INC.	+4.65%	1.62B

Diagnostic & Testing Substances